Kiwa Bio-Tech Announces Opening Of First Research and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
44
Kiwa Bio-Tech Announces Opening Of First Research and Development Center In China

ONTARIO, CA, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Kiwa Bio-Tech Products Group Corp. (OTCQB: KWBT) (“Kiwa Bio-Tech” or “the Company”), a leading agricultural biotechnology company that develops and manufactures microbial fertilizers for use in the multi-billion agricultural industry announced that the Company has inaugurated its new state-of-the-art research center related to its rapidly expanding microbial fertilizer business in China.

The purpose of establishing the new Kiwa-Yangling Ecological Agriculture and Environment Research Center (“Kiwa R&D Center”) is to create a headquarters for conducting original research on microbial fertilizers and to make innovative advances in its KETS core technology and support Kiwa Bio-Tech’s strategy of opening new agricultural planting markets and safeguarding the Company’s leading position in the soil restoration industry.

“Research is at the center of everything we do. We reinvest 12% of our revenue annually in new innovation and continue to upgrade our soil-smart technology. The Kiwa R & D Center will also accept government subsidies to support its agricultural research. With sufficient financial support, our innovation pipeline could redefine the industry,” stated Kiwa Bio-Tech’s CEO, Ms. Wang.

The new Kiwa R&D Center is located in the only High-Tech Agricultural Free Trade Zone in Yangling, Shaanxi Province. This location will give Kiwa Bio-Tech access to one of the largest agricultural industry clusters in China. With these geo-advantages and cluster competitive advantages, the Kiwa R&D Center has already established a Research and Innovation Division, Laboratories, an International Cooperation Division, a Data and Information Division and Personnel Training Division. 

“The agricultural industry in China has historically faced a lack of industrial standards for bio-fertilizers, which has resulted in a low level of biotechnology advancement and achievement and severe agricultural pollution. The Company’s research and development begins with a thorough understanding of the necessities for transforming agricultural research achievements, bridging between biotechnologies and market demands, developing eco-friendly agricultural standards and alleviating the soil pollution caused by the use of chemical fertilizers,” added Ms. Wang. 

We see the Kiwa R & D Center playing a role in fostering dynamic collaboration between academia and the agricultural industry to enhance the knowledge and understanding of eco-friendly agriculture to address far-reaching challenges. The Kiwa R&D Center cooperates with Northwest Agriculture and Forestry University, China Agricultural University, Chinese Academy of Agricultural Sciences, Northwest University, Harbin Technology Institute, Research Institute of Tsinghua University and several other prestigious universities.

The Company has appointed Dr. Yanan Tong as the first president of the Kiwa R & D Center. Dr. Tong received his Ph.D. from Swedish University of Agricultural Sciences. His research direction includes fertilizer use and environment, agricultural environmental protection, and soil sciences. Dr. Tong has served as the Secretary-General of the UK-China Sustainable Agriculture Innovation Network to promote agricultural cooperation and food security in the United Kingdom and China.

About Kiwa Bio-Tech Products Group Corp.

Leader in Eco-friendly Agricultural Industry Chain

Kiwa Bio-Tech Products Group Corp. (KWBT) is a publicly traded company with corporate headquarters in the United States. The company develops, manufacture, markets and distributes innovative and environmentally safe bio-technological products for agriculture. Kiwa’s focus is to positively impact the environment by reducing the amount of chemicals that are being used by agricultural growers in China.

Kiwa Bio-Tech Products Group corp. products are covered by patent protection and are designed to enhance the quality of human life by increasing the value and productivity of agricultural crops.  

For more information on Kiwa Bio-Tech Products Group Corp.  or its bio-fertilizer products and smart soil remediation technology, please refer to the Company’s website at  www.kiwabiotech.com  or the Company filings with the United States Securities and Exchange Commission at  www.sec.gov .

Forward-Looking Statements

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company’s reports filed with the U.S. Securities and Exchange Commission. The forward-looking information provided herein represents the Company’s estimates as of the date of the press release, and subsequent events and developments may cause the Company’s estimates to change. The Company’s actual results may differ materially from those anticipated in the forward-looking statements depending on a number of risk factors including, but not limited to, the following: general economic, business and environment conditions, development, shipment, market acceptance, additional competition from existing and new competitors, changes in technology, the execution of its ten-year growth plan, the foreign exchange risk amid the unexpected announcements by the PRC government and various other factors beyond the Company’s control.  Kiwa Bio-Tech Products Group Corp. specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company’s estimates of its future financial performance as of any date subsequent to the date of this press release.

Contact: Kiwa Bio-Tech Products Group Corporation Molly Han  Investor & Media Relations Tel: 909-456-8827 molly@kiwabiotech.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 120

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 99

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 710

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Onodrim Raises $300M to Propel EU Defence Future

Updated Category News Views 20

Onodrim Industries' Bold Bid to Reshape European Security Right out of the gate, Onodrim Industries is thundering onto the scene with a hefty $300 million Series A round to flex its muscles across Europe's defence and industrial sectors. This ain't your run-of-the-mill startup story. This is about flexing hard-earned capital to snap up established players and inject a...

Continue Reading
Wuliangye Aims for Global Branding Boost at Panda Event

Updated Category News Views 179

Wuliangye Takes Center Stage at Global Event Everyone's chasing that global branding magic, but here's Wuliangye strutting its stuff at the Global Panda Partners Conference. Held in Sichuan Province from November 2 to 4, this is not just another show; it's a bold move from the Chinese baijiu maker to push the 'harmony and coexistence' mantra on the world stage. Not just...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 312

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
KT&G Launches Heated Tobacco in Kazakhstan's Market

Updated Category News Views 43

KT&G Lights Up Kazakhstan In a bold move, KT&G is laying down the gauntlet in Kazakhstan's tobacco market, introducing its cutting-edge heated tobacco gizmo and a handful of sleek FAIIM sticks. Launching this October, these aren't just any devices—they're the FLEX locals have been waiting for, rebranded from South Korea's lil AIBLE and AIIM but made to fit right in with...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 474

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
AI Shopping Surge: WeFetch.ai's Bold Rebrand Move

Updated Category News Views 134

Shifting Gears: GreenCore Solutions Becomes WeFetch.ai Here's a shift you don't see every day. GreenCore Solutions has morphed into WeFetch.ai, aiming to sail the ever-growing AI shopping seas. This isn't just a new nameplate; it's a declaration of intent to dive headfirst into the market dynamics driven by artificial intelligence. It's bold and, frankly, pretty timely....

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 172

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Traditions Bancorp Declares New Cash Dividend for Investors

Updated Category News Views 76

Traditions Bancorp Declares Quarterly Cash Dividend On a recent date, the Board of Directors of Traditions Bancorp (OTC: TRBK), the parent company of Traditions Bank, announced a quarterly cash dividend of eight cents per common share. This dividend reflects the company's strong commitment to returning value to its shareholders and will be disbursed shortly. The payment...

Continue Reading
LONGi BC Tech Paves the Way for Solar Leadership in Europe

Updated Category News Views 334

LONGi's Impact on Europe's Solar Industry LONGi, recognized as a leader in solar technology, has made remarkable strides in reshaping the renewable energy scene in Europe. With an impressive 10GW of back contact (BC) modules deployed, the continent is rapidly becoming a hotbed for high-efficiency solar solutions. This accomplishment underlines the company's crucial...

Continue Reading
PACS Group Investors: Important Actions to Take Now

Updated Category News Views 152

Important Deadline for PACS Group Investors Investors in PACS Group, Inc. are advised to take note of an important lead plaintiff application deadline related to recent securities class action lawsuits. If you have incurred losses exceeding $100,000 in the company's stock, you may be eligible to participate in these legal proceedings. Class Action Lawsuit Details The...

Continue Reading
Exploring Market Sentiment Around Morningstar Inc and Its Trends

Updated Category News Views 207

Understanding Morningstar Inc's Market Position Morningstar Inc (NYSE:MORN) has recently shown a notable decline in its short interest, with a decrease of 9.22% reported. Currently, there are approximately 655 thousand shares sold short, constituting about 2.56% of the total shares available for trading. This information is pivotal for investors since it reflects the...

Continue Reading
Julie Springer Expands Legal Services with Mediation Practice

Updated Category News Views 363

Julie Springer's New Ventures in Mediation In the dynamic legal scene of Austin, seasoned attorney Julie A. Springer is making waves by broadening her practice to include mediation and arbitration services. This thoughtful transition reflects her long-time dedication to effectively settling business disputes, educational conflicts, and employment issues. Professional...

Continue Reading